Match!

Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR–Cas9 genome editing

Published on Nov 1, 2017in Nature Biomedical Engineering17.135
· DOI :10.1038/s41551-017-0145-2
Bruna S. Paulsen2
Estimated H-index: 2
(Harvard University),
Pankaj K. Mandal20
Estimated H-index: 20
(Harvard University)
+ 11 AuthorsDerrick J. Rossi52
Estimated H-index: 52
Sources
Abstract
Gene disruption by clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 (Cas9) is highly efficient and relies on the error-prone non-homologous end-joining pathway. Conversely, precise gene editing requires homology-directed repair (HDR), which occurs at a lower frequency than non-homologous end-joining in mammalian cells. Here, by testing whether manipulation of DNA repair factors improves HDR efficacy, we show that transient ectopic co-expression of RAD52 and a dominant-negative form of tumour protein p53-binding protein 1 (dn53BP1) synergize to enable efficient HDR using a single-stranded oligonucleotide DNA donor template at multiple loci in human cells, including patient-derived induced pluripotent stem cells. Co-expression of RAD52 and dn53BP1 improves multiplexed HDR-mediated editing, whereas expression of RAD52 alone enhances HDR with Cas9 nickase. Our data show that the frequency of non-homologous end-joining-mediated double-strand break repair in the presence of these two factors is not suppressed and suggest that dn53BP1 competitively antagonizes 53BP1 to augment HDR in combination with RAD52. Importantly, co-expression of RAD52 and dn53BP1 does not alter Cas9 off-target activity. These findings support the use of RAD52 and dn53BP1 co-expression to overcome bottlenecks that limit HDR in precision genome editing.
  • References (76)
  • Citations (11)
📖 Papers frequently viewed together
18 Citations
35 Citations
521 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References76
Newest
#1Jungmin LeeH-Index: 4
#2Brad DykstraH-Index: 7
Last. Derrick J. RossiH-Index: 52
view all 10 authors...
7 CitationsSource
#1Jiangtao Ren (UPenn: University of Pennsylvania)H-Index: 4
#2Xiaojun Liu (UPenn: University of Pennsylvania)H-Index: 13
Last. Yangbing Zhao (UPenn: University of Pennsylvania)H-Index: 34
view all 6 authors...
Purpose: Using gene-disrupted allogeneic T cells as universal effector cells provides an alternative and potentially improves current chimeric antigen receptor (CAR) T-cell therapy against cancers and infectious diseases. Experimental Design: The CRISPR/Cas9 system has recently emerged as a simple and efficient way for multiplex genome engineering. By combining lentiviral delivery of CAR and electro-transfer of Cas9 mRNA and gRNAs targeting endogenous TCR, β-2 microglobulin (B2M) and PD1 simulta...
196 CitationsSource
#1Daniel P. DeverH-Index: 12
#2Rasmus O. BakH-Index: 20
Last. Matthew H. PorteusH-Index: 46
view all 16 authors...
These preclinical studies outline a CRISPR-based methodology for correcting β-globin gene mutations in haematopoietic stem cells to advance the development of next-generation therapies for β-haemoglobinopathies.
247 CitationsSource
#1Keiichiro SuzukiH-Index: 39
#2Yuji TsunekawaH-Index: 8
view all 35 authors...
A method for CRISPR-based genome editing that harnesses cellular non-homologous end joining activity to achieve targeted DNA knock-in in non-dividing tissues.
309 CitationsSource
#1Kritika HanamshetH-Index: 4
#2Olga M. MazinaH-Index: 16
Last. Alexander V. MazinH-Index: 26
view all 3 authors...
Homologous recombination (HR) plays an important role in maintaining genomic integrity. It is responsible for repair of the most harmful DNA lesions, DNA double-strand breaks and inter-strand DNA cross-links. HR function is also essential for proper segregation of homologous chromosomes in meiosis, maintenance of telomeres, and resolving stalled replication forks. Defects in HR often lead to genetic diseases and cancer. Rad52 is one of the key HR proteins, which is evolutionarily conserved from ...
29 CitationsSource
#1Ragini Bhargava (City of Hope National Medical Center)H-Index: 2
#2David O. Onyango (City of Hope National Medical Center)H-Index: 3
Last. Jeremy M. Stark (City of Hope National Medical Center)H-Index: 25
view all 3 authors...
Single-strand annealing (SSA) is a DNA double-strand break (DSB) repair pathway that uses homologous repeats to bridge DSB ends. SSA involving repeats that flank a single DSB causes a deletion rearrangement between the repeats, and hence is relatively mutagenic. Nevertheless, this pathway is conserved, in that SSA events have been found in several organisms. In this review, we describe the mechanism of SSA and its regulation, including the cellular conditions that may favor SSA versus other DSB ...
90 CitationsSource
#1Fena OchsH-Index: 3
#2Kumar SomyajitH-Index: 13
Last. Claudia LukasH-Index: 41
view all 6 authors...
A new study reveals that 53BP1 influences high-fidelity homology-directed repair by showing that its depletion in the presence of increasing DNA-damage levels triggers a shift from RAD51-dependent gene conversion, an error-free process, to RAD52-mediated single-strand annealing, which is mutagenic.
91 CitationsSource
#1Sarah R. Hengel (UI: University of Iowa)H-Index: 4
#2Eva Malacaria (ISS: Istituto Superiore di Sanità)H-Index: 5
Last. Maria Spies (UI: University of Iowa)H-Index: 21
view all 11 authors...
Cells are constantly in danger of losing or scrambling critical genetic information because of DNA damage. To cope with this stress, cells have numerous DNA repair systems. One of these systems – homology-directed DNA repair – involves the proteins BRCA1 and BRCA2, which are often missing or defective in breast and ovarian cancers. The BRCA-deficient cancer cells can still survive, but become “addicted” to other DNA repair proteins – among them a protein called RAD52. It might be possible to kil...
25 CitationsSource
#1Jiazhi HuH-Index: 12
#2Robin M. MeyersH-Index: 17
Last. Richard L. FrockH-Index: 14
view all 6 authors...
This protocol describes a genome-wide method to detect and to quantify DNA double-stranded breaks (DSBs). The approach is applicable to endogenous DSBs, but it can also be used to characterize the activity of engineered nucleases, including Cas9.
54 CitationsSource
#2Graham J. RayH-Index: 4
Last. Jacob E. CornH-Index: 32
view all 5 authors...
The efficiency of homology-directed genome editing with CRISPR-Cas9 is boosted through improved design of donor DNA.
388 CitationsSource
Cited By11
Newest
#1Kun XuH-Index: 24
#2David J. SegalH-Index: 40
Last. Zhiying ZhangH-Index: 13
view all 3 authors...
Source
#1Pierre Billon (Columbia University)H-Index: 2
#1Pierre Billon (Columbia University)H-Index: 1
Last. Han S. Ryu (Columbia University)
view all 16 authors...
Summary Genome editing technologies have transformed our ability to engineer desired genomic changes within living systems. However, detecting precise genomic modifications often requires sophisticated, expensive, and time-consuming experimental approaches. Here, we describe DTECT (Dinucleotide signaTurE CapTure), a rapid and versatile detection method that relies on the capture of targeted dinucleotide signatures resulting from the digestion of genomic DNA amplicons by the type IIS restriction ...
Source
#1Andrés Lamsfus-Calle (University of Tübingen)H-Index: 2
#2Alberto Daniel-Moreno (University of Tübingen)H-Index: 2
Last. Markus Mezger (University of Tübingen)H-Index: 17
view all 7 authors...
Abstract Due to pioneering in vitro investigations on gene modification, gene engineering platforms have incredibly improved to a safer and more powerful tool for the treatment of multiple blood and immune disorders. Likewise, several clinical trials have been initiated combining autologous hematopoietic stem cell transplantation (auto-HSCT) with gene therapy (GT) tools. As several GT modalities such as lentivirus and gene editing tools have a long developmental path ahead to diminish its negati...
1 CitationsSource
#1Xiaoyu Chen (LUMC: Leiden University Medical Center)H-Index: 7
#2Francesca Tasca (LUMC: Leiden University Medical Center)H-Index: 1
Last. Manuel A. F. V. Gonçalves (LUMC: Leiden University Medical Center)H-Index: 23
view all 11 authors...
Genome editing typically involves recombination between donor nucleic acids and acceptor genomic sequences subjected to double-stranded DNA breaks (DSBs) made by programmable nucleases (e.g. CRISPR-Cas9). Yet, nucleases yield off-target mutations and, most pervasively, unpredictable target allele disruptions. Remarkably, to date, the untoward phenotypic consequences of disrupting allelic and non-allelic (e.g. pseudogene) sequences have received scant scrutiny and, crucially, remain to be address...
1 CitationsSource
Chimeric antigen receptor (CAR)-modified T cells have raised among other immunotherapies for cancer treatment, being implemented against B-cell malignancies. Despite the promising outcomes of this innovative technology, CAR-T cells are not exempt from limitations that must yet to be overcome in order to provide reliable and more efficient treatments against other types of cancer. The purpose of this review is to shed light on the field of CAR-T cell gene editing for therapy universalization and ...
Source
#1Charles D. Yeh (ETH Zurich)H-Index: 1
#2Christopher D. Richardson (UCSB: University of California, Santa Barbara)H-Index: 1
Last. Jacob E. Corn (ETH Zurich)H-Index: 32
view all 3 authors...
Eukaryotic cells deploy overlapping repair pathways to resolve DNA damage. Advancements in genome editing take advantage of these pathways to produce permanent genetic changes. Despite recent improvements, genome editing can produce diverse outcomes that can introduce risks in clinical applications. Although homology-directed repair is attractive for its ability to encode precise edits, it is particularly difficult in human cells. Here we discuss the DNA repair pathways that underlie genome edit...
11 CitationsSource
#1Tarun S. Nambiar (Columbia University)H-Index: 1
#2Pierre Billon (Columbia University)H-Index: 1
Last. Alberto Ciccia (Columbia University)H-Index: 20
view all 13 authors...
Precise editing of genomic DNA can be achieved upon repair of CRISPR-induced DNA double-stranded breaks (DSBs) by homology-directed repair (HDR). However, the efficiency of this process is limited by DSB repair pathways competing with HDR, such as non-homologous end joining (NHEJ). Here we individually express in human cells 204 open reading frames involved in the DNA damage response (DDR) and determine their impact on CRISPR-mediated HDR. From these studies, we identify RAD18 as a stimulator of...
1 CitationsSource
#1Rajeswari Jayavaradhan (Cincinnati Children's Hospital Medical Center)H-Index: 2
#2Devin Pillis (Cincinnati Children's Hospital Medical Center)H-Index: 3
Last. Punam Malik (University of Cincinnati Academic Health Center)H-Index: 26
view all 7 authors...
Precise genome editing/correction of DNA double-strand breaks (DSBs) induced by CRISPR-Cas9 by homology-dependent repair (HDR) is limited by the competing error-prone non-homologous end-joining (NHEJ) DNA repair pathway. Here, we define a safer and efficient system that promotes HDR-based precise genome editing, while reducing NHEJ locally, only at CRISPR-Cas9-induced DSBs. We fused a dominant-negative mutant of 53BP1, DN1S, to Cas9 nucleases, and the resulting Cas9-DN1S fusion proteins signific...
Source
#1Holly A. Rees (Broad Institute)H-Index: 10
#2Wei-Hsi YehH-Index: 3
Last. David R. Liu (Broad Institute)H-Index: 73
view all 3 authors...
In mammalian cells, double-stranded DNA breaks (DSBs) are preferentially repaired through end-joining processes that generally lead to mixtures of insertions and deletions (indels) or other rearrangements at the cleavage site. In the presence of homologous DNA, homology-directed repair (HDR) can generate specific mutations, albeit typically with modest efficiency and a low ratio of HDR products:indels. Here, we develop hRad51 mutants fused to Cas9(D10A) nickase (RDN) that mediate HDR while minim...
Source
#1Renata M. Martin (Stanford University)H-Index: 3
#2Kazuya Ikeda (Stanford University)H-Index: 2
Last. Matthew H. Porteus (Stanford University)H-Index: 46
view all 21 authors...
Summary Genome editing of human pluripotent stem cells (hPSCs) provides powerful opportunities for in vitro disease modeling, drug discovery, and personalized stem cell-based therapeutics. Currently, only small edits can be engineered with high frequency, while larger modifications suffer from low efficiency and a resultant need for selection markers. Here, we describe marker-free genome editing in hPSCs using Cas9 ribonucleoproteins (RNPs) in combination with AAV6-mediated DNA repair template d...
4 CitationsSource